# Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs

> **NCT03876210** · PHASE1 · COMPLETED · sponsor: **PMG Pharm Co., Ltd** · enrollment: 47 (actual)

## Conditions studied

- Arthritis

## Interventions

- **COMBINATION_PRODUCT:** PK101
- **DRUG:** PK101-001, PK101-002

## Key facts

- **NCT ID:** NCT03876210
- **Lead sponsor:** PMG Pharm Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-12
- **Primary completion:** 2019-07-22
- **Final completion:** 2019-08-05
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03876210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03876210, "Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03876210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*